Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

May 30, 2016 | REGULATORY

96 % of early stage pancreatic cancer patients detected in a clinical validation study with a North American sample cohort

Read press release
April 26, 2016 | REGULATORY

Immunovia kallar till årsstämma 2016

Read press release
April 8, 2016 | REGULATORY

Immunovia appoints Dr. Marco Del Chiaro from Karolinska Institute to Scientific Advisory Board

Read press release
March 9, 2016 | REGULATORY

Immunovia partners with leading healthcare consultingservices firm

Read press release
February 29, 2016 | REGULATORY

Immunovia starts collaboration with multinational life science company on new systemic lupus erythematosus (SLE) diagnostics test

Read press release
February 24, 2016 | REGULATORY

Immunovia Year-end report 2015

Read press release
February 10, 2016 | REGULATORY

Immunovia and Lund University start clinical validation studies of Systemic Lupus Erythematosus (SLE) biomarker signatures

Read press release
February 9, 2016 | REGULATORY

Immunovia announces collaboration with Mount Sinai Health System to validate early detection blood test for pancreatic cancer

Read press release
January 19, 2016 | REGULATORY

Immunovia and the University of Liverpool enter into a collaboration in a prospective clinical study

Read press release
December 18, 2015 | REGULATORY

White Paper outlines predicted impact of new biomarker diagnostic technology on pancreatic cancer survival rates

Read press release
December 3, 2015 | REGULATORY

IMMray™ PanCan-d detects 98% of pancreatic cancers in retrospective study with 1400 blood samples

Read press release
December 2, 2015 | REGULATORY

Immunovia’s stock increased 60 percent on first day of trading on Nasdaq First North with a turnover of SEK 28.5 million

Read press release
1 … 13 14 15
Home Press releases Page 15